Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.
Sec. Cardiovascular Metabolism
Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1549900
This article is part of the Research Topic Inflammatory Pathways in Cardiometabolic Diseases: Mechanisms, Biomarkers, and Therapeutic Insights View all 4 articles

Alterations in Bile Acid Metabolites Associated with Pathogenicity and IVIG Resistance in Kawasaki Disease

Provisionally accepted
Yifei Li Yifei Li 1*Xinqi Wang Xinqi Wang 2Linli Han Linli Han 1Jiyang Jiang Jiyang Jiang 2Zhenxin Fan Zhenxin Fan 2Yimin Hua Yimin Hua 2Libang He Libang He 2
  • 1 West China Second University Hospital, Sichuan University, Chengdu, China
  • 2 Sichuan University, Chengdu, Sichuan Province, China

The final, formatted version of the article will be published soon.

    Background: Kawasaki disease (KD) primarily affects children as an acute systemic vasculitis. Numerous studies indicated an elevated risk of cardiovascular disease due to metabolic disturbances. Despite this knowledge, the specific metabolic modes involved in KD remain unclear.We examined the metabolome of individuals with 108 KD and 52 non-KD controls (KD vs nKD) by ultraperformance liquid chromatography (UPLC) and tandem mass spectrometry (MS).Results: Differential analysis uncovered the disturbed production of bile acids and lipids in KD. Furthermore, we investigated the impact of treatment, intravenous immunoglobulin (IVIG) resistance, and coronary artery (CA) occurrence on the metabolome. Our findings suggested that IVIG treatment alters the lipid and amino acid metabolism of KD patients. By orthogonal projections to latent structures discriminant analysis (OPLS-DA), there was no significant difference between the coronary injury groups and non-coronary injury groups, and IVIG resistance didn't appear to cause the metabolic change in KD patients.Patients with KD exhibit metabolic abnormalities, particularly in bile acids and lipids. IVIG interventions may partially ameliorate these lipid abnormalities.

    Keywords: Kaeasaki diseases Kaeasaki 病 Kaeasaki 病 Kaeasaki 病, metabolome analysis 代谢组分析 Metabolome analysis, coronary artery injuries 冠状动脉损伤 Coronary artery injuries, IVIG resistance 静脉注射免疫球蛋白耐药性 Ivig resistance, Intravenous immunoglobulin resistance, bile acid 胆汁酸 Bile acid, lipids 脂类 Lipids

    Received: 22 Dec 2024; Accepted: 10 Feb 2025.

    Copyright: © 2025 Li, Wang, Han, Jiang, Fan, Hua and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yifei Li, West China Second University Hospital, Sichuan University, Chengdu, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.